|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S1
|
$75,000
|
$1,500
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S2
|
$333,000
|
$6,660
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S3
|
$200,000
|
$4,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-35S4
|
$150,000
|
$3,000
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-35
|
$2,522,007
|
$50,440
|
LYNCH, THOMAS
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
1U10CA180826-01
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-02
|
$2,232,714
|
$357,234
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Wnt Signaling and Secreted Frizzled-Related Proteins
|
ZIA BC 010251
|
$211,597
|
$21,160
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
WHI Hormones and Gynecologic Cancers Study
|
ZIA CP010126 - 10538
|
$136,848
|
$68,424
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$77,422
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$29,378
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
1U10CA180870-01
|
$648,000
|
$32,400
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
1U10CA180858-01
|
$1,192,600
|
$29,815
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-07S1
|
$355,196
|
$10,656
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-07
|
$1,535,000
|
$46,050
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
5UM1CA164973-03
|
$3,743,675
|
$374,368
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
UCDCCC NCTN U10 Program
|
1U10CA180846-01
|
$700,250
|
$17,506
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
TRANSPORTERS IN METFORMIN TREATMENT OF ENDOMETRIAL HYPERPLASIA
|
5R03CA176796-02
|
$73,720
|
$73,720
|
THAKKER, DHIREN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-09
|
$407,137
|
$138,427
|
BODURKA, DIANE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-30
|
$617,613
|
$209,988
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
The Role of Bioactive Lipids in Inflammation and Cancer
|
5P01CA077839-13
|
$1,047,419
|
$345,648
|
DUBOIS, RAYMOND
|
MAYO CLINIC ARIZONA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S3
|
$21,615
|
$432
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S1
|
$75,000
|
$1,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S2
|
$50,000
|
$1,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S3
|
$77,097
|
$1,542
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$93,723
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The pathophysiology and palliation of the paclitaxel-induced acute pain syndrome
|
1R21CA180997-01
|
$192,765
|
$48,191
|
JATOI, AMINAH
|
MAYO CLINIC ROCHESTER
|
|
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and
|
5R01CA162139-03
|
$558,986
|
$184,465
|
BARAKAT, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The critical role of GRP78 for endometrial cancer development and progression
|
1K08CA175161-01A1
|
$175,824
|
$175,824
|
LIN-LIU, YVONNE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting the Mullerian Inhibiting Substance pathway in gynecologic cancer
|
5R01CA148747-05
|
$307,889
|
$76,972
|
CLIBY, WILLIAM
|
MAYO CLINIC ROCHESTER
|
|
Targeted Therapy for Endometrial Cancer
|
5R01CA099908-12
|
$244,874
|
$244,874
|
LESLIE, KIMBERLY
|
UNIVERSITY OF IOWA
|
|
Systematic Functional Characterization of RNA Editing in Endometrial Cancer
|
1R01CA175486-01A1
|
$332,000
|
$332,000
|
LIANG, HAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SWOG Network Group Operations Center of the NCTN
|
1U10CA180888-01
|
$13,829,118
|
$138,291
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Structural mutation analysis of PTEN and its possible genotype-phenotype correlat
|
5F31CA174316-03
|
$28,178
|
$14,089
|
SMITH, IRIS
|
UNIVERSITY OF HOUSTON
|
|
Statistical Methods for Normalizing Microarrays in Cancer Biomarker Studies
|
5R01CA151947-04
|
$295,445
|
$147,723
|
QIN, LI-XUAN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Stabilizing nuclear p27kip1 as a therapeutic target for endometrial cancer
|
1R01CA176502-01A1
|
$639,657
|
$639,657
|
GOLD, LESLIE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Silent Markers in Endometrial and Ovarian Tissue
|
ZIA CP010126 - 10302
|
$170,282
|
$85,141
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$94,615
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Revving-Up Exercise for Sustained Weight-Loss by Altering Neurological Reward & D
|
5R01CA175100-02
|
$496,360
|
$496,360
|
NOCK, NORA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Prospective Study of Serum MIS and Gynecologic Cancer Risk
|
5R01CA163018-03
|
$388,102
|
$194,051
|
DORGAN, JOANNE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Polish Gynecologic Cancer Case-Control Study
|
ZIA CP010126 - 10524
|
$121,604
|
$60,802
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
Pilot Study: Collection Analysis of Human Ovarian Surface Epithelial Cells
|
ZIA CP010144 - 10376
|
$49,710
|
$24,855
|
Wentzensen, Nicolas
|
DCEG (NCI)
|
|
OSU as Network Lead Academic Participating Site for the NCI NCTN
|
1U10CA180850-01
|
$1,455,849
|
$36,396
|
GOLDBERG, RICHARD
|
OHIO STATE UNIVERSITY
|
|
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
|
1U10CA180868-01
|
$18,813,807
|
$235,173
|
WOLMARK, NORMAN
|
NRG ONCOLOGY FOUNDATION, INC.
|
|
NRG ONCOLOGY NETWORK GROUP OPERATIONS CENTER
|
3U10CA180868-01S1
|
$146,524
|
$1,832
|
WOLMARK, NORMAN
|
NRG ONCOLOGY FOUNDATION, INC.
|
|
Novel epigenetic paradigm in endometrial cancer recurrence
|
1R01CA172279-01A1
|
$308,364
|
$308,364
|
HUANG, TIM
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Norwegian Studies of the Association of Pregnancy and Perinatal Characteristics with Cancer Risk in Mothers and Offspring
|
ZIA CP010168 - 10041
|
$50,686
|
$5,069
|
Troisi, Rebecca
|
DCEG (NCI)
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
$7,372
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.
|
1U10CA180866-01
|
$616,000
|
$10,780
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
NCTN Lead Academic Participating Sites Application
|
1U10CA180838-01
|
$623,050
|
$31,153
|
CAREY, LISA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Total relevant funding to Uterine for this search: $15,506,505
|